Provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.
cirrhosis portal hypertension varices mri magnetic resonance imaging beta-blockers beta blockers